Method of production of a methionine salt
US-9403764-B2 · Aug 2, 2016 · US
US9920005B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9920005-B2 |
| Application number | US-201615281942-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 30, 2016 |
| Priority date | Mar 24, 2008 |
| Publication date | Mar 20, 2018 |
| Grant date | Mar 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for highly efficiently preparing high purity crystals of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chloro-phenyl]-ethyl]-1,3-propanediol hydrochloride. The method involves dissolving 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol in a mixed solvent comprising a solvent in which its hydrochloride is highly soluble and a solvent in which its hydrochloride is less soluble, to prepare a solution of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol; and then adding hydrochloric acid to the resulting solution with stirring, to crystallize the hydrochloride of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chloro-phenyl]ethyl]-1,3-propanediol.
Opening claim text (preview).
What is claimed is: 1. A method for crystallizing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol hydrochloride, comprising: dissolving 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol in ethanol with heating; adding ethyl acetate to the ethanol containing the 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol, resulting in a first solution; adding 1 to 12 mole/L of hydrochloric acid to the first solution at a temperature in a range of 50° C. to 90° C. while stirring, resulting a second solution; and forming crystalline particles of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol hydrochloride from the second solution at a temperature in a range of from 0° C. to 30° C. while stirring, wherein an amount of a mixed solvent comprising the ethanol and the ethyl acetate ranges from 20 to 50 times a mass of the 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-ethyl]-1,3-propanediol. 2. The method of claim 1 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a tip speed of not less than 50 m/min. 3. The method of claim 1 , wherein the adding of the hydrochloric acid is carried out at a temperature in a range of from 60° C. to 70° C. 4. The method of claim 1 , wherein the hydrochloric acid has a concentration ranging from 3 to 6 mole/L. 5. The method of claim 1 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C. 6. The method of claim 2 , wherein the adding of the hydrochloric acid is carried out at a temperature in a range of from 60° C. to 70° C. 7. The method of claim 2 , wherein the hydrochloric acid has a concentration ranging from 3 to 6 mole/L. 8. The method of claim 2 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C. 9. The method of claim 3 , wherein the hydrochloric acid has a concentration ranging from 3 to 6 mole/L. 10. The method of claim 3 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C. 11. The method of claim 4 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C. 12. The method of claim 6 , wherein the hydrochloric acid has a concentration ranging from 3 to 6 mole/L. 13. The method of claim 6 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C. 14. The method of claim 7 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C. 15. The method of claim 9 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C. 16. The method of claim 12 , wherein the forming of the crystalline particles is carried out while stirring the second solution at a temperature in a range of from 5° C. to 25° C.
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Drugs for immunological or allergic disorders · CPC title
for joint disorders, e.g. arthritis, arthrosis · CPC title
Crystalline forms, e.g. polymorphs · CPC title
Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine (atenolol A61K31/165; pindolol A61K31/404; timolol A61K31/5377) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.